The Coronavirus Outbreak liveLatest Updates Maps and Cases Delta Variant F.A.Q.s C.D.C. School Guidance Advertisement Continue reading the main story Supported by Continue reading the main story Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is… Read More »
A longer, 10-month delay in administering second doses of AstraZeneca’s COVID-19 vaccine afforded trial participants stronger immunity, the company announced Monday, aiming to assuage concerns of compromised immunity among populations of countries with short vaccine supply. Researchers with the University of Oxford posted findings on The Lancet’s preprint server Monday, drawing from trial participants aged… Read More »
A group of government health officials and medical organizations issued a statement supporting the COVID-19 vaccines for adolescents and young adults after a meeting of a special advisory committee with the Centers for Disease Control and Prevention. “The vaccines are safe and effective, and they prevent COVID-19 illness. They will help protect you and your… Read More »
Breadcrumb Trail Links Health You might think clinical trials might provide some answers about which vaccine is ‘best,’ particularly the large phase 3 trials, but direct comparison is complex Author of the article: Wen Shi Lee and Hyon Xhi Tan, The Conversation Every vaccine delivered is a small but significant step towards global normality. Photo by… Read More »